Page 142 - MemoriaES-Eng

RESEARCH GROUPS

é
í

á
é

íí

é

PROGRAMME:
Group 31
COPD

Group Members
Lead Researcher

óRuiz-Cabello Osuna, Jesús
STAFF MEMBERS
Groult, Hugo

Prez Medina, Carlos
Contact:
Prez Snchez, Jos Manuel
á
Dep. of Epidemiology, Atherothrombosis and Imaging Salinas Rodrguez, Beatriz
Fundacin C. Nnal. de Investigaciones Cardiovasculares
ASSOCIATED MEMBERS
C/ Melchor Fernndez Almagro, 3. Madrid
Phone: (+34) 91 453 12 00 -Ext. 4150 · E.mail: [email protected] Benito Vicente, Marina
Website: http://www.cnic.es/es/unidades/imagen/index.php
Bilbao Luri, Izaskun

Carrero Gonzalez, Laura
Cruz Vadell, Abel
Main lines of research
Herranz Rabanal, Fernando
Pellico Saez, Juan
The group is integrated in the Advanced Imaging Unit (AIU) that was estab-
Rdguez. Ramrez de Arellano, Ignacio
lished in the Spanish National Centre for Cardiovascular Imaging in early
Salinas Rodrguez, Beatriz
Villa Valverde, Palmira
2012. It is a multidisciplinary group focused in developing new imaging
applications and molecular imaging developments that will expand the mo-

lecular and cellular knowledge of the different cardiovascular and pulmo-
nary diseases. With this aim our research is focused on 1) Cardiovascular

and Pulmonary Imaging 2) Nanomedicine and radiochemistry and 3) Me-

tabolomics. The group offers the scientific community state of the art imag-
ing technologies including five modalities: MRI, X-ray CT, nuclear imaging

(PET), ultrasound (echocardiography) and optical (bi and tri-dimensional 13
20
luminescence and fluorescence). In the field of Nanomedicine the group T
encompasses a nanotechnology and organic chemistry laboratory in which R
PO
we develop new nanoparticles, molecular probes and biofunctionalization E
techniques for the diagnosis and treatment of different cardiovascular and L R
A
pulmonary diseases. Currently our group produces multifunctional nano- NU
N
particles for all imaging techniques available at our institution, like Iron A
Oxide, liposomes, Up-converting Nanophosphors and Gold Nanoparticles, /
ES
all of them functionalized with different cardiovascular and pulmonary bio- ER
B
markers. Additionally, a new 68Ga (and from beginning of 2014) 89Zr ra- CI
diochemistry laboratory is fully operative to provide specific PET radiotrac-

142
ers for nuclear imaging. Finally, the group also has a long experience in the
application of metabolic analysis to the study of different pathologies, by